2024 | | Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease | 이광재 |
2023 | | Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | 이광재 |
2023 | | Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study | 이광재 |
2023 | | On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study | 이광재 |
2023 | | Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis | 이광재 |
2023 | | Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study | 이광재 |
2023 | | Real-world Prescription Patterns and Patient Satisfaction Regarding Maintenance Therapy of Gastroesophageal Reflux Disease: An Observational, Cross-sectional, Multicenter Study | 이광재 |
2023 | | Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study | 이광재 |
2023 | | Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis | 이광재 |
2022 | | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea | 이광재 |
2022 | | On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis | 이광재 |
2022 | | Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis | 이광재 |
2021 | | Multicenter, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of a Controlled-release, Once-daily UIC201609/UIC201610 Combination Therapy for Functional Dyspepsia: Preliminary Study | 이광재 |
2021 | | 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease | 이광재 |
2021 | | The usefulness of symptom-based subtypes of functional dyspepsia for predicting underlying pathophysiologic mechanisms and choosing appropriate therapeutic agents | 이광재 |
2021 | | Efficacy and safety of DWJ1252 compared with gasmotin in the treatment of functional dyspepsia: A multicenter, randomized, double-blind, active-controlled study | 이광재 |
2020 | | The Usefulness of Esophageal Baseline Impedance Levels for the Diagnosis of Nonerosive Reflux Disease and the Proper Time for Measurement in Endoscopy-negative Korean Patients With Esophageal or Supraesophageal Symptoms | 노충균, 이광재 |
2020 | | Fecal Microbiota Alterations and Small Intestinal Bacterial Overgrowth in Functional Abdominal Bloating/Distention | 노충균, 이광재 |
2020 | | 2019 Seoul Consensus on Esophageal Achalasia Guidelines | 이광재 |
2019 | | Monomorphic epitheliotropic intestinal T cell lymphoma presenting in weblike feature | 노진, 노충균, 이광재 |
2019 | | Analysis of endoscopic features for histologic discrepancies between biopsy and endoscopic submucosal dissection in gastric neoplasms: 10-year results | 김순선, 김영배, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 이다근, 임선교, 정재연, 조효정 |
2019 | | Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn's disease | 이광재 |
2019 | | A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조효정, 황재철 |
2019 | | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus | 김순선, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 정재연, 조효정, 황재철 |
2019 | | Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis | 이광재 |
2019 | | Comparisons of the Mucosal Healing Process between Flat and Protruded Type after Endoscopic Submucosal Dissection for Gastric Neoplasms | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 조효정, 황재철 |
2018 | | Gastrointestinal Gas and Abdominal Fat Quantity Measured by Three-Dimensional Abdominal Computed Tomography in Patients with Functional Bloating | 김재근, 선주성, 이광재 |
2018 | | Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial. | 이광재, 임선교 |
2018 | | Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals | 노충균, 이광재, 정재연 |
2017 | | Non-steroidal anti-inflammatory drug-induced enteropathy | 노충균, 신성재, 이광재, 이기명, 임선교 |
2017 | | Alterations of Food-specific Serum IgG4 Titers to Common Food Antigens in Patients With Irritable Bowel Syndrome | 이광재 |
2017 | | Anti-fibrogenic effect of PPAR-gamma agonists in human intestinal myofibroblasts | 신성재, 이광재, 이기명 |
2017 | | The NO/cGMP pathway in duodenal motor, mechano- and chemosensory responses to acid: A randomized, placebo-controlled study with sildenafil in healthy volunteers | 이광재 |
2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
2017 | | Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies | 김대중, 이광재 |
2017 | | The Effect of Acute Stress on Esophageal Motility and Gastroesophageal Reflux in Healthy Humans | 노충균, 이광재 |
2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
2016 | | Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition | 이광재 |
2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
2016 | | Endoscopic naso-gallbladder drainage versus gallbladder stenting before cholecystectomy in patients with acute cholecystitis and a high suspicion of choledocholithiasis: a prospective randomised preliminary study | 김순선, 김욱환, 김지훈, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2016 | | Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study | 이광재 |
2016 | | Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats | 이광재 |
2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
2015 | | Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease | 이광재 |
2015 | | Pharmacologic treatment for inflammatory bowel disease | 이광재 |
2015 | | Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. | 이광재 |
2015 | | Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. | 양민재, 이광재, 임선교 |
2015 | | Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia. | 이광재 |
2015 | | Pharmacologic Agents for Chronic Diarrhea. | 이광재 |
2015 | | Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study. | 이광재 |